| Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response CS Manno, GF Pierce, VR Arruda, B Glader, M Ragni, JJE Rasko, ... Nature medicine 12 (3), 342-347, 2006 | 2446 | 2006 |
| CD8+ T-cell responses to adeno-associated virus capsid in humans F Mingozzi, MV Maus, DJ Hui, DE Sabatino, SL Murphy, JEJ Rasko, ... Nature medicine 13 (4), 419-422, 2007 | 834 | 2007 |
| Hemophilia B gene therapy with a high-specific-activity factor IX variant LA George, SK Sullivan, A Giermasz, JEJ Rasko, BJ Samelson-Jones, ... New England Journal of Medicine 377 (23), 2215-2227, 2017 | 750 | 2017 |
| Gene therapy in patients with transfusion-dependent β-thalassemia AA Thompson, MC Walters, J Kwiatkowski, JEJ Rasko, JA Ribeil, ... New England Journal of Medicine 378 (16), 1479-1493, 2018 | 730 | 2018 |
| ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer M Van Geldermalsen, Q Wang, R Nagarajah, AD Marshall, A Thoeng, ... Oncogene 35 (24), 3201-3208, 2016 | 576 | 2016 |
| Orchestrated intron retention regulates normal granulocyte differentiation JJL Wong, W Ritchie, OA Ebner, M Selbach, JWH Wong, Y Huang, D Gao, ... Cell 154 (3), 583-595, 2013 | 485 | 2013 |
| BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved … DI Loukinov, E Pugacheva, S Vatolin, SD Pack, H Moon, I Chernukhin, ... Proceedings of the National Academy of Sciences 99 (10), 6806-6811, 2002 | 443 | 2002 |
| Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development Q Wang, RA Hardie, AJ Hoy, M Van Geldermalsen, D Gao, L Fazli, ... The Journal of pathology 236 (3), 278-289, 2015 | 364 | 2015 |
| Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers CG Fedele, LM Ooms, M Ho, J Vieusseux, SA O'Toole, EK Millar, ... Proceedings of the National Academy of Sciences 107 (51), 22231-22236, 2010 | 335 | 2010 |
| Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells J Holst, S Watson, MS Lord, SS Eamegdool, DV Bax, LB Nivison-Smith, ... Nature biotechnology 28 (10), 1123-1128, 2010 | 310 | 2010 |
| Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19 HF Seow, S Bröer, A Bröer, CG Bailey, SJ Potter, JA Cavanaugh, ... Nature genetics 36 (9), 1003-1007, 2004 | 304 | 2004 |
| Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 … HP Kiem, RG Andrews, J Morris, L Peterson, S Heyward, JM Allen, ... Blood, The Journal of the American Society of Hematology 92 (6), 1878-1886, 1998 | 302 | 1998 |
| Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder A Bröer, K Klingel, S Kowalczuk, JEJ Rasko, J Cavanaugh, S Bröer Journal of Biological Chemistry 279 (23), 24467-24476, 2004 | 294 | 2004 |
| The RD114/simian type D retrovirus receptor is a neutral amino acid transporter JEJ Rasko, JL Battini, RJ Gottschalk, I Mazo, AD Miller Proceedings of the National Academy of Sciences 96 (5), 2129-2134, 1999 | 281 | 1999 |
| A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction JL Battini, JEJ Rasko, AD Miller Proceedings of the National Academy of Sciences 96 (4), 1385-1390, 1999 | 281 | 1999 |
| Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive … RL Basser, JEJ Rasko, K Clarke, J Cebon, MD Green, AP Grigg, ... Blood, The Journal of the American Society of Hematology 89 (9), 3118-3128, 1997 | 258 | 1997 |
| Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer RL Basser, JEJ Rasko, K Clarke, J Cebon, MD Green, S Hussein, C Alt, ... The Lancet 348 (9037), 1279-1281, 1996 | 254 | 1996 |
| IRFinder: assessing the impact of intron retention on mammalian gene expression R Middleton, D Gao, A Thomas, B Singh, A Au, JJL Wong, A Bomane, ... Genome biology 18, 1-11, 2017 | 247 | 2017 |
| Targeting glutamine transport to suppress melanoma cell growth Q Wang, KA Beaumont, NJ Otte, J Font, CG Bailey, M van Geldermalsen, ... International journal of cancer 135 (5), 1060-1071, 2014 | 245 | 2014 |
| Genome-wide characterization of the routes to pluripotency SMI Hussein, MC Puri, PD Tonge, M Benevento, AJ Corso, JL Clancy, ... Nature 516 (7530), 198-206, 2014 | 244 | 2014 |
